527 related articles for article (PubMed ID: 14557214)
1. Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation.
Feldstein A; Elmer PJ; Orwoll E; Herson M; Hillier T
Arch Intern Med; 2003 Oct; 163(18):2165-72. PubMed ID: 14557214
[TBL] [Abstract][Full Text] [Related]
2. Low calcaneal bone mineral density and the risk of distal forearm fracture in women and men: a population-based case-control study.
Atroshi I; Ahlander F; Billsten M; Ahlborg HG; Mellström D; Ohlsson C; Ljunggren O; Karlsson MK
Bone; 2009 Oct; 45(4):789-93. PubMed ID: 19539795
[TBL] [Abstract][Full Text] [Related]
3. Adherence with osteoporosis practice guidelines: a multilevel analysis of patient, physician, and practice setting characteristics.
Solomon DH; Brookhart MA; Gandhi TK; Karson A; Gharib S; Orav EJ; Shaykevich S; Licari A; Cabral D; Bates DW
Am J Med; 2004 Dec; 117(12):919-24. PubMed ID: 15629730
[TBL] [Abstract][Full Text] [Related]
4. Compliance with osteoporosis treatment guidelines in postmenopausal women.
Mountjoy CR; Shrader SP; Ragucci KR
Ann Pharmacother; 2009 Feb; 43(2):242-50. PubMed ID: 19196838
[TBL] [Abstract][Full Text] [Related]
5. [CBO guideline 'Osteoporosis' (second revision].
Pols HA; Wittenberg J
Ned Tijdschr Geneeskd; 2002 Jul; 146(29):1359-63. PubMed ID: 12162173
[TBL] [Abstract][Full Text] [Related]
6. Osteoporosis and vertebral compression fractures-continued missed opportunities.
Freedman BA; Potter BK; Nesti LJ; Giuliani JR; Hampton C; Kuklo TR
Spine J; 2008; 8(5):756-62. PubMed ID: 18343730
[TBL] [Abstract][Full Text] [Related]
7. Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study.
Kaptoge S; Benevolenskaya LI; Bhalla AK; Cannata JB; Boonen S; Falch JA; Felsenberg D; Finn JD; Nuti R; Hoszowski K; Lorenc R; Miazgowski T; Jajic I; Lyritis G; Masaryk P; Naves-Diaz M; Poor G; Reid DM; Scheidt-Nave C; Stepan JJ; Todd CJ; Weber K; Woolf AD; Roy DK; Lunt M; Pye SR; O'neill TW; Silman AJ; Reeve J
Bone; 2005 Mar; 36(3):387-98. PubMed ID: 15777673
[TBL] [Abstract][Full Text] [Related]
8. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Bone mineral measurements and guideline].
Fukunaga M; Sone T
Clin Calcium; 2008 Aug; 18(8):1089-95. PubMed ID: 18677045
[TBL] [Abstract][Full Text] [Related]
9. Osteoporosis: evaluation of screening patterns in a primary-care group practice.
Cohen K; Maier D
J Clin Densitom; 2008; 11(4):498-502. PubMed ID: 18835537
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density thresholds for pharmacological intervention to prevent fractures.
Siris ES; Chen YT; Abbott TA; Barrett-Connor E; Miller PD; Wehren LE; Berger ML
Arch Intern Med; 2004 May; 164(10):1108-12. PubMed ID: 15159268
[TBL] [Abstract][Full Text] [Related]
11. Follow-up for osteoporosis in older patients three years after a fracture.
Schurink M; Hegeman JH; Kreeftenberg HG; Ten Duis HJ
Neth J Med; 2007 Feb; 65(2):71-4. PubMed ID: 17379932
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral density measurement and osteoporosis treatment after a fragility fracture in older adults: regional variation and determinants of use in Quebec.
Vanasse A; Dagenais P; Niyonsenga T; Grégoire JP; Courteau J; Hemiari A
BMC Musculoskelet Disord; 2005 Jun; 6():33. PubMed ID: 15969760
[TBL] [Abstract][Full Text] [Related]
13. Underuse of procedures for diagnosing osteoporosis and of therapies for osteoporosis in older nursing home residents.
Gupta G; Aronow WS
J Am Med Dir Assoc; 2003; 4(4):200-2. PubMed ID: 12837141
[TBL] [Abstract][Full Text] [Related]
14. Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture.
Perreault S; Dragomir A; Blais L; Moride Y; Rossignol M; Ste-Marie LG; Fernandès JC
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):248-59. PubMed ID: 18213734
[TBL] [Abstract][Full Text] [Related]
15. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC
Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
[TBL] [Abstract][Full Text] [Related]
16. Screening for osteoporosis in the adult U.S. population: ACPM position statement on preventive practice.
Lim LS; Hoeksema LJ; Sherin K;
Am J Prev Med; 2009 Apr; 36(4):366-75. PubMed ID: 19285200
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of bisphosphonate therapy in a community setting.
Feldstein AC; Weycker D; Nichols GA; Oster G; Rosales G; Boardman DL; Perrin N
Bone; 2009 Jan; 44(1):153-9. PubMed ID: 18926939
[TBL] [Abstract][Full Text] [Related]
18. [Absolute risk for fracture and WHO guideline. Fracture risk assessments recommended by World Health Organization and Japanese guidelines for prevention and treatment of osteoporosis 2006].
Nakamura T;
Clin Calcium; 2007 Jul; 17(7):1022-8. PubMed ID: 17607068
[TBL] [Abstract][Full Text] [Related]
19. Osteoporosis in older men and women.
Kenny AM; Joseph C; Taxel P; Prestwood KM
Conn Med; 2003 Sep; 67(8):481-6. PubMed ID: 14587128
[TBL] [Abstract][Full Text] [Related]
20. Low bone mineral density and fracture burden in postmenopausal women.
Cranney A; Jamal SA; Tsang JF; Josse RG; Leslie WD
CMAJ; 2007 Sep; 177(6):575-80. PubMed ID: 17846439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
